Sender Company & Partners’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,600
Closed -$408K 114
2025
Q3
$408K Buy
+8,600
New +$416K 0.04% 286

Other funds holding AKRO